LifeMD Inc (NASDAQ:LFMD) Focuses on Core Telehealth Services to Enhance Market Position

Font: Financial Modeling Prep  • Mar 12, 2026

• LifeMD Inc (NASDAQ:LFMD) divests its WorkSimpli business to concentrate on its primary telehealth and pharmacy services, aiming for operational efficiency and market share growth.
• A price target of $10 set by Loop Capital Markets indicates a significant potential upside from its current trading price.
• The company's low trading multiple and the launch of the Wegovy pill are expected to drive future growth.

LifeMD Inc (NASDAQ:LFMD) is a telehealth and pharmacy provider that has recently undergone strategic changes to enhance its market position. The company divested its WorkSimpli business to focus on its core offerings. This move is expected to streamline operations and potentially increase its market share in the telehealth sector.

On March 12, 2026, Ilya Zubkov from Loop Capital Markets set a price target of $10 for LFMD. At that time, the stock was trading at $3.88, suggesting a potential price increase of approximately 42.27%. Currently, the stock is priced at $3.87, reflecting a slight decrease of 4.68% with a change of $0.19.

LifeMD is trading at a low multiple of 0.796 times its trailing twelve-month sales. This low multiple indicates potential upside if the multiples revert to higher levels. The company's recent launch of the Wegovy pill is anticipated to drive growth within its GLP-1 vertical, further strengthening its market position.

The stock has fluctuated between a low of $3.86 and a high of $4.30 today. Over the past year, it reached a high of $15.84 and a low of $2.56. With a market capitalization of approximately $186.3 million, LFMD is actively traded with a volume of 1,062,494 shares on the NASDAQ exchange.